HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HLA class II genotypes associated with chronic hepatitis C virus infection and response to alpha-interferon treatment in Poland.

AbstractAIMS/BACKGROUND:
Recent evidence suggests that spontaneous clearance of hepatitis C virus (HCV) may be associated with the HLA DQB1*0301 allele but there is still some debate over the role of other alleles and HLA haplotypes in HCV infection. As this may best be resolved by studying genetically different populations, we have investigated HLA class II-encoded susceptibility and resistance to HCV infection in a relatively sedentary population of patients from northwestern Poland.
METHODS:
The distributions of HLA class II DRB1, DQA1, DQB1 and DPB1 alleles were determined by standard PCR-protocol in 129 unrelated patients with chronic hepatitis C (anti-HCV and HCV-RNA positive) and 103 healthy unrelated racially-matched control subjects. Fifty-five patients were treated with alpha-interferon (5 MIU thrice weekly for 6 months) out of whom 29 showed a complete response and 26 were non-responders.
RESULTS:
A significantly reduced frequency of the DQB1*0301 allele in the patients was observed (24.0% vs. 38.8%; p=0.015). Additionally, two different DR-DQ haplotypes were found to be associated with chronic HCV infection: DRB1*1501-DQA1*01-DQB1*0602 (24.0% vs. 12.6%; p= 0.027) and DRB1*0701-DQA1*0201-DQB1*02 (31.8 vs. 12.6%; p=0.0006), the latter difference being most pronounced in those patients who responded to alpha-interferon treatment (41.4% vs. 12.6%; p=0.00048).
CONCLUSIONS:
The results confirm the negative association between chronic HCV and DQB1*0301 and identify two novel genetic associations. In particular, the DRB1*0701-DQA1*0201-DQB1*02 haplotype is associated with both chronic infection and response to alpha-interferon. Interestingly, the same haplotype is reportedly associated with non-response to hepatitis B vaccination.
AuthorsM Wawrzynowicz-Syczewska, J A Underhill, M A Clare, A Boron-Kaczmarska, I G McFarlane, P T Donaldson
JournalLiver (Liver) Vol. 20 Issue 3 Pg. 234-9 (Jun 2000) ISSN: 0106-9543 [Print] Denmark
PMID10902974 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • DNA Probes, HLA
  • HLA-DR Antigens
  • Hepatitis C Antigens
  • Interferon-alpha
  • DNA
Topics
  • Adult
  • Aged
  • DNA (analysis)
  • DNA Probes, HLA (chemistry)
  • Female
  • Gene Frequency
  • Genes, MHC Class II
  • Genetic Predisposition to Disease
  • HLA-DR Antigens (genetics)
  • Haplotypes
  • Hepacivirus (drug effects, isolation & purification)
  • Hepatitis C Antigens (blood)
  • Hepatitis C, Chronic (drug therapy, immunology, virology)
  • Histocompatibility
  • Humans
  • Immunity, Innate (genetics)
  • Interferon-alpha (therapeutic use)
  • Male
  • Middle Aged
  • Poland
  • Polymerase Chain Reaction
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: